Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04194554
Title A Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition and Stereotactic Body Radiotherapy in Prostate Cancer (ASCLEPIuS)
Recruitment Recruiting
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors University of Michigan Rogel Cancer Center

prostate adenocarcinoma


Abiraterone + Leuprolide + Niraparib + Prednisone

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Michigan Rogel Cancer Center Recruiting Ann Arbor Michigan 48109 United States Details
Weill Cornell Medicine Recruiting New York New York 10065 United States Details
University Hospitals Seidman Cancer Center Recruiting Cleveland Ohio 44106 United States Details
University of Texas Southwestern Recruiting Dallas Texas 75390 United States Details
*Shaded cells indicate that there was no data available from for the field